Concepedia

Cytokine Variant Optimization

Cytokine Variant Optimization is a computational or experimental method that systematically refines the amino acid sequence or structural properties of cytokine variants to enhance their therapeutic efficacy, stability, or target specificity within the context of protein engineering.

1

Publications

16

Citations

17

Authors

1

Institutions

Publications per year

2017–2026

0

Parents

Publications

1

1–1 of 1

Authors

17

  1. BK
    Barbara K. Klein

    Monsanto (United States), United States

    1 publications · 16 citations

    1

    h-index

  2. PO
    Peter O. Olins

    Monsanto (United States), United States

    1 publications · 16 citations

    1

    h-index

  3. AM
    Alan M. Easton

    Pfizer (United States), United States

    1 publications · 16 citations

    1

    h-index

  4. JP
    John P. McKearn

    Monsanto (United States), United States

    1 publications · 16 citations

    1

    h-index

  5. SR
    Sarah R. Braford

    Monsanto (United States), United States

    1 publications · 16 citations

    1

    h-index

1–5 of 17

Institutions

1

  1. Monsanto (United States)

    Creve Coeur, United States

    1 h-index

    17 publications

    272 citations

1–1 of 1

Venues

  1. Experimental Hematology

    1 publications · 16 citations

    1

    h-index

1–1